Incidence and Risk Factors for Breakthrough Invasive Mold Infections in Acute Myeloid Leukemia Patients Receiving Remission Induction Chemotherapy

BACKGROUND: Despite fungal prophylaxis, invasive mold infections (IMIs) are a significant cause of morbidity and mortality in patients with acute myeloid leukemia (AML) receiving remission induction chemotherapy. The choice of antifungal prophylaxis agent remains controversial, especially in the era...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Heena P, Perissinotti, Anthony J, Patel, Twisha S, Bixby, Dale L, Marshall, Vincent D, Marini, Bernard L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Editor's Choice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524834/
https://www.ncbi.nlm.nih.gov/pubmed/31123689
http://dx.doi.org/10.1093/ofid/ofz176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524834/
https://www.ncbi.nlm.nih.gov/pubmed/31123689
http://dx.doi.org/10.1093/ofid/ofz176

Ejemplares similares